Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marker...
Hypertension Diagnostics reported revenue of $3.79 million for fiscal year 2018, up 3.1% from fiscal year 2017, and net income of -$125,388. In Q3 2019 (the quarter ended September 30, 2019) revenue was $0.
Figures from company filings; latest fiscal year ended December 31, 2018.
No profile data available.